pembrolizumab
merck
['nhl', 'pembro', 'ptcl']
#ash22 ph 2: pembrolizumab after asct in t-cell nhl. started within 21 days. primary endpoint of pfs met. os not reached at 36 months. #bmtsm 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??